
Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline Validated by European Medicines Agency
Kyowa Kirin Co., Ltd. (TSE: 4151 President and CEO: Masashi Miyamoto, “Kyowa Kirin”)announces that its marketing authorisation application (MAA) for...